Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • 5-HT Receptor
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Cannabinoid Receptor
    (1)
  • Cysteine Protease
    (1)
  • E1/E2/E3 Enzyme
    (1)
  • EGFR
    (1)
  • GHSR
    (1)
  • Kisspeptin
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

s130

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Antibody Products
    4
    TargetMol | Antibody_Products
S130
T128191160852-22-1
S130 is a high affinity, selectiveATG4B (a major cysteine protease) inhibitor (IC50 of 3.24 μM).It suppresses autophagy flux.
  • $297
6-8 weeks
Size
QTY
NS13001
N-(4-chlorophenyl)-2-(3,5-dimethylpyrazol-1-yl)-9-methylpurin-6-amine, N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine
T163451063331-94-1
NS13001 (N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine) is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 μM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias.
  • $45
In Stock
Size
QTY
RS130-180
T211542
RS130-180 is a β-arrestin-biased agonist that selectively targets the 5-hydroxytryptamine 2A receptor (5-HT2aR). It shows promise for research in neuropsychiatric disorders such as depression.
  • Inquiry Price
Inquiry
Size
QTY
KLS-13019
KLS13019, KLS 13019
T324021801243-39-9
KLS-13019 is a highly effective and orally active GPR55 receptor antagonist, a cannabidiol (CBD)-derived neuroprotective agent that can reverse chemotherapy-induced peripheral neuropathy (CIPN) and is suitable for studying hepatic encephalopathy (HE).
  • $497
In Stock
Size
QTY
Allitinib
AST-1306, ALS 1306
T14336897383-62-9
Allitinib (AST-1306) (AST-1306) has anti-cancer activity,and it is an irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. [1]
  • $48
In Stock
Size
QTY
Athidathion
GS-13006
T1433919691-80-6
Thiophos (GS-13006) is an insecticide, which is an organic phosphate ester.
  • $1,520
6-8 weeks
Size
QTY
CTS-1027
RS 130830, Ro 1130830
T15015193022-04-7
CTS-1027 is a small molecule inhibitor of MMPs (IC50s: 0.3 nM, 0.5 nM for MMP2, MMP13). It has > 1,000 fold selectivity over MMP1.
  • $97
5 days
Size
QTY
Macimorelin acetate
EP-1572 acetate ; AEZS-130 acetate, EP-1572 acetate, AEZS-130 acetate
T68276945212-59-9
Macimorelin Acetate (EP-1572), an orally active growth hormone (GH) secretagogue and a ghrelin receptor (GHSR) agonist, stimulates GH release. It is utilized in research focusing on adult growth hormone deficiency (AGHD) and Cancer Anorexia-Cachexia Syndrome (CACS).
  • $528
8-10 weeks
Size
QTY
KISS1-305
TP1467872717-97-0
KISS1-305, the Metastin/Kisspeptin analog, is a prototype peptide and chemical probe that resists plasma protease degradation but has suboptimal KISS1R agonistic activity in vitro.
  • $1,330
35 days
Size
QTY
Navtemadlin
CS-1300, AMG232
TQ01271352066-68-2
Navtemadlin (AMG232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction (IC50: 0.6 nM). It binds to MDM2 with a Kd of 0.045 nM.
  • $67
In Stock
Size
QTY